Based on some of these comments, I think there is some misconception about the nature of this study by Harrow. It was a naturalistic study, and Harrow had nothing to do with the “treatment.” People who were “psychotic” were treated in the hospital with antipsychotics (conventional treatment.) They were discharged and then Harrow and Thomas Jobe simply followed up with them periodically for the next 20 years (followups were at 2 years, 4.5 years, 7.5 years, 10 years, 15 years and 20 years.) Some people stopped taking antipsychotics during the first two years, and other kept on taking the drugs. All Harrow did at the two year follow-up was report on this medication use, and he did so at each of the follow-ups. What he found, when he analyzed his followup data at the end of 15 and 20 years, that those patients who, for whatever reason, had taken themselves off antipsychotics by the 2-year follow-up (many may have stopped soon after being discharged from the hospital, and thus only been on antipsychotics for a short time) had by far the best outcomes over the long term, and many who had stopped using antipsychotics by year two never took the drugs again. Among the people who were still taking antipsychotics at year two, many may have taken themselves off the drugs by some later date, at least for a time. But what Harrow found was this: the best outcomes by far were those who had stopped taking the drugs at the two-year followup. So what you see in this naturalistic stud, which means Harrow was simply studying people who were diagnosed with a psychotic disorder and treated conventionally in the hospital by hospital staff and seeing how they fared over the long term. There was no protocol that called for anyone to go off the drugs by year two. Harrow just observed stark differenced between the long-term outcomes between those who had rejected the antipsychotics by year two, and those who were medication compliant during the study.